1.Cancer Stem Cells in Primary Liver Cancers: Pathological Concepts and Imaging Findings.
Ijin JOO ; Haeryoung KIM ; Jeong Min LEE
Korean Journal of Radiology 2015;16(1):50-68
There is accumulating evidence that cancer stem cells (CSCs) play an integral role in the initiation of hepatocarcinogenesis and the maintaining of tumor growth. Liver CSCs derived from hepatic stem/progenitor cells have the potential to differentiate into either hepatocytes or cholangiocytes. Primary liver cancers originating from CSCs constitute a heterogeneous histopathologic spectrum, including hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma with various radiologic manifestations. In this article, we reviewed the recent concepts of CSCs in the development of primary liver cancers, focusing on their pathological and radiological findings. Awareness of the pathological concepts and imaging findings of primary liver cancers with features of CSCs is critical for accurate diagnosis, prediction of outcome, and appropriate treatment options for patients.
Bile Duct Neoplasms/pathology/radiography
;
Bile Ducts, Intrahepatic/pathology/radiography
;
Carcinoma, Hepatocellular/pathology/radiography
;
Cholangiocarcinoma/pathology/radiography
;
Humans
;
Liver Neoplasms/*pathology/radiography
;
Magnetic Resonance Imaging
;
Neoplastic Stem Cells/*pathology/radiography
;
Tomography, X-Ray Computed
2.Combined Hepatocellular-cholangiocarcinoma.
Joon Koo HAN ; Se Hyung KIM ; Soo Jin KIM
The Korean Journal of Hepatology 2007;13(1):112-115
4.Radiological Staging of Hilar Cholangiocarcinoma.
The Korean Journal of Gastroenterology 2005;46(1):7-15
Hilar cholangiocarcinoma is an adenocarcinoma arising from the bile duct epithelium, at the confluence of the right and left intrahepatic bile ducts, within the porta hepatis. In most cases, hilar cholangiocarcinomas are locally invasive tumors which have dismal prognosis if left untreated, with mean survival of approximately three months after the initial presentation. Recently, preoperative assessment of resectability and staging of hilar cholangiocarcinoma has gained importance in better management of the patients. Non-invasive cross-sectional radiological imaging has made considerable advances, and staging of hilar cholangiocarcinomas using radiological examination became more accurate in recent years. In this review, staging of hilar cholangiocarcinoma using computed tomography, magnetic resonance imaging, magnetic resonance cholangiopancreatography, and magnetic resonance angiography is described.
Bile Duct Neoplasms/*diagnosis/radiography
;
*Bile Ducts, Intrahepatic/pathology/radiography
;
Cholangiocarcinoma/*diagnosis/radiography
;
Cholangiopancreatography, Magnetic Resonance
;
Humans
;
Magnetic Resonance Angiography
;
Magnetic Resonance Imaging
;
Tomography, X-Ray Computed
6.Composite liver tumors: A radiologic-pathologic correlation.
Megha NAYYAR ; David K IMAGAWA ; Temel TIRKES ; Aram N DEMIRJIAN ; Roozbeh HOUSHYAR ; Kumar SANDRASEGARAN ; Chaitali S NANGIA ; Tara SEERY ; P BHARGAVA ; Joon II CHOI ; Chandana LALL
Clinical and Molecular Hepatology 2014;20(4):406-410
Bi-phenotypic neoplasm refers to tumors derived from a common cancer stem cell with unique capability to differentiate histologically into two distinct tumor types. Bi-phenotypic hepatocellular carcinoma-cholangiocarcinoma (HCC-CC), although a rare tumor, is important for clinicians to recognize, since treatment options targeting both elements of the tumor are crucial. Imaging findings of bi-phenotypic HCC-CC are not specific and include features of both HCC and CC. A combination of imaging and immuno-histochemical analysis is usually needed to make the diagnosis.
CA-19-9 Antigen/metabolism
;
Carcinoma, Hepatocellular/mortality/pathology/radiography
;
Cholangiocarcinoma/mortality/pathology/radiography
;
Humans
;
Liver Neoplasms/mortality/pathology/*radiography
;
Magnetic Resonance Imaging
;
Phenotype
;
Risk Factors
;
Survival Analysis
;
Tomography, X-Ray Computed
;
alpha-Fetoproteins/analysis
7.A Case of Cholangiocarcinoma Suspected by Continuous Elevation of CA 19-9 after Surgery of Xanthogranulomatous Cholecystitis.
Sang Youn HWANG ; Joon Suk KIM ; Ji Bong JEONG ; Ji Won KIM ; Byeong Gwan KIM ; Kook Lae LEE ; Young Joon AHN ; Mee Soo CHANG
The Korean Journal of Gastroenterology 2010;55(6):404-409
Xanthogranulomatous cholecystitis (XGC) is an unusual and destructive inflammatory process that is characterized by thickening of the gallbladder (GB) wall with a tendency to adhere to neighboring organs. XGC is often mistaken for GB carcinoma, and the frequency of the coexistence of these two lesions is approximately 10%. Therefore, in case of severe XGC, there is chance of either overlooking the carcinoma or other significant lesions. CA 19-9 is commonly measured in the serum of patients with hepatobiliary malignancies. Although CA 19-9 can be elevated in benign conditions such as cholestasis, pancreatitis, tuberculosis, thyroid disease etc., malignancy should be considered at first in setting of its significant and persistent elevation. We report a case of a 62-year-old man who showed continuously rising level of CA19-9 over 2000 U/mL after cholecystectomy for xanthogranulomatous cholecystitis and finally was diagnosed as cholangiocarcinoma by short-term follow up.
Bile Duct Neoplasms/*diagnosis/pathology/radiography
;
*Bile Ducts, Intrahepatic
;
CA-19-9 Antigen/*blood
;
Cholangiocarcinoma/*diagnosis/pathology/radiography
;
Cholecystitis/pathology/*surgery
;
Granuloma/pathology/*surgery
;
Humans
;
Male
;
Middle Aged
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
;
Xanthomatosis/pathology/*surgery
8.Modified Retroperitoneal Access for Percutaneous Intervention after Pancreaticoduodenectomy.
Korean Journal of Radiology 2013;14(3):446-450
Percutaneous access to the surgical bed after pancreaticoduodenectomy can be a challenge, due to the post-operative anatomy alteration. However, immediate complications, such as surgical bed abscess or suspected tumor recurrence, are often best accessed percutaneously, as open surgical or endoscopic approaches are often difficult, if not impossible. We, hereby, describe a safe approach that is highly replicable, in accessing the surgical bed for percutaneous intervention, following pancreaticoduodenectomy.
Abscess/radiography/therapy
;
Bile Duct Neoplasms/pathology/radiography
;
Biopsy/methods
;
Catheterization/*methods
;
Cholangiocarcinoma/pathology/radiography
;
Drainage/instrumentation/*methods
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/pathology/radiography
;
Pancreatic Diseases/radiography/therapy
;
*Pancreaticoduodenectomy
;
Postoperative Complications/radiography/*therapy
;
Radiography, Interventional/methods
;
Retroperitoneal Space
9.Synchronous Double Primary Hepatic Cancer: Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Jin Ok KIM ; Dae Won JUN ; Kiseok JANG
The Korean Journal of Gastroenterology 2013;62(2):135-139
No abstract available.
Bile Duct Neoplasms/*diagnosis/pathology/radiography
;
Carcinoma, Hepatocellular/*diagnosis/radiography/therapy
;
Chemoembolization, Therapeutic
;
Cholangiocarcinoma/*diagnosis/pathology/radiography
;
Humans
;
Immunohistochemistry
;
Keratin-7/metabolism
;
Liver Neoplasms/*diagnosis/pathology/radiography/therapy
;
Male
;
Middle Aged
;
Neoplasms, Multiple Primary/*diagnosis/pathology/radiography
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
10.A Newly Designed Y-shaped Covered Stent in the Palliative Treatment of Hepatic Hilar Malignant Obstruction: Case Report.
Byung Chul KANG ; So Yon LEE ; Hwan Hoon CHUNG
Korean Journal of Radiology 2013;14(1):97-101
We report a case in an inoperable patient with the hilar malignant biliary obstruction treated palliatively by the use of a newly designed Y-shaped covered stent without interfering contra-lateral bile duct. We percutaneously inserted a newly designed Y-shaped covered stent into a biliary tree in an inoperable patient with Bismuth Type II cholangiocarcinoma. We checked tubograms, enhanced CT studies, and blood bilirubin levels before, one week after, and at every three month after the stenting, by observing closely the signs of clinical infection as well. The follow-up period was about 12 months. The placement of the Y-shaped covered stent was successful and resulted in adequate biliary drainage in the immediate post-procedural tubogram and in the follow-up abdominal CT. The serum bilirubin levels did not show elevation after the insertion of the Y-shaped covered stent.
Aged
;
Bile Duct Neoplasms/pathology/radiography/*therapy
;
*Bile Ducts, Intrahepatic
;
Bilirubin/blood
;
Cholangiocarcinoma/pathology/radiography/*therapy
;
Cholangiography
;
Drainage/instrumentation
;
Female
;
Humans
;
*Palliative Care
;
Prosthesis Design
;
*Stents
;
Tomography, X-Ray Computed